ID: ALA5206517

Max Phase: Preclinical

Molecular Formula: C24H20ClNO7

Molecular Weight: 469.88

Representations

Canonical SMILES:  O=CN1[C@H](C(=O)Oc2ccccc2Cl)Cc2cc(O)c(O)cc2[C@@H]1Cc1ccc(O)c(O)c1

Standard InChI:  InChI=1S/C24H20ClNO7/c25-16-3-1-2-4-23(16)33-24(32)18-9-14-10-21(30)22(31)11-15(14)17(26(18)12-27)7-13-5-6-19(28)20(29)8-13/h1-6,8,10-12,17-18,28-31H,7,9H2/t17-,18-/m0/s1

Standard InChI Key:  XGEFABNOSYKHMX-ROUUACIJSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 469.88

Molecular Weight (Monoisotopic): 469.0928

AlogP: 3.43

#Rotatable Bonds: 5

Polar Surface Area: 127.53

Molecular Species: NEUTRAL

HBA: 7

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 8.93

CX Basic pKa:

CX LogP: 4.09

CX LogD: 4.08

Aromatic Rings: 3

Heavy Atoms: 33

QED Weighted: 0.19

Np Likeness Score: 0.38

References

1. Liu Z, Gu S, Zhu X, Liu M, Cao Z, Qiu P, Li S, Liu S, Song G..  (2022)  Discovery and optimization of new 6, 7-dihydroxy-1, 2, 3, 4-tetrahydroisoquinoline derivatives as potent influenza virus PA_N inhibitors.,  227  [PMID:34700269] [10.1016/j.ejmech.2021.113929]

Source

Source(1):

• Scientific Literature